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During the systemic inflammatory response of severe
sepsis, neutrophils accumulate in the liver microcir-
culation, but their functional significance is largely
unknown. We show that neutrophils migrate to liver
sinusoids during endotoxemia and sepsis where
they exert protective effects by releasing neutrophil
extracellular traps (NETs), which are DNA-based
structures that capture and eliminate microbes.
NETs released into the vasculature ensnare bacteria
from the bloodstream and prevent dissemination.
NET production requires platelet-neutrophil interac-
tions and can be inhibited by platelet depletion or
disruption of integrin-mediated platelet-neutrophil
binding. During sepsis, NET release increases bac-
terial trapping by 4-fold (beyond the basal level
provided by resident intravascular macrophages).
Blocking NET formation reduces the capture of circu-
lating bacteria during sepsis, resulting in increased
dissemination to distant organs. Thus, NETs ensnare
circulating bacteria and provide intravascular immu-
nity that protects against bacterial dissemination
during septic infections.
INTRODUCTION
The microvascular environment is home to a variety of immuno-
logical processes, collectively termed intravascular immunity
(Hickey and Kubes, 2009). Our current understanding of intra-
vascular immunity primarily involves the patrolling/surveillance
of blood vessels by resident intravascular leukocytes that
mediate rapid detection and initiation of responses to infection
or tissue injury (Hickey and Kubes, 2009). However, in addition
to surveillance, the ability to mount protective innate immune
responses within the vasculature (including effector mecha-
nisms that can withstand the shear forces of flowing blood)
may be critical to host defense against blood-borne infections
such as severe bacterial sepsis.
Severe sepsis is a syndrome of systemic inflammation in
response to infection that leads to organ dysfunction, shock,
and death in 20%–50% of patients (Dombrovskiy et al., 2007).324 Cell Host & Microbe 12, 324–333, September 13, 2012 ª2012 ElA central feature of the inflammatory pathology of acute sepsis
is accumulation of activated neutrophils within the microcircula-
tion of highly vascular organs such as the liver, leading to
immune-mediated tissue damage and organ dysfunction (Brown
et al., 2006; Dhainaut et al., 2001). The reasons for this seemingly
inappropriate sequestration of neutrophils within the microvas-
culature of the liver are unknown. Many have hypothesized
that this represents a clever immune evasion strategy by
bacteria, in which the release of proinflammatory bacterial prod-
ucts into the bloodmisdirects neutrophils away from the focus of
infection and into central organs including the liver. However,
recent evidence demonstrating that neutrophils are actively
recruited to liver sinusoidsduring endotoxemia/sepsis by a highly
coordinated adhesion mechanism provides evidence for an
alternate hypothesis, that neutrophils are actively targeted to
the vasculature of the liver as part of a coordinated host defense
strategy (McDonald et al., 2008; Menezes et al., 2009). Indeed,
previous studies have suggested that neutrophils recruited to
the liver after intravenous bacterial infection enhanced the
clearance of pathogens from the circulation (Clark et al., 2007;
Gregory et al., 1996). However, the mechanism by which neu-
trophils contribute to intravascular immunity against septic
bacterial infections is unknown.
In addition to infiltrating neutrophils, liver sinusoids are also
home to a vast network of resident intravascular macrophages
(Kupffer cells), as well as specialized endothelial cells that
express multiple scavenger receptors and are highly endocytic
(Crispe, 2009). However, reliance on receptor-mediated capture
and phagocytosis of individual microbes may be overcome
during overwhelming septic bacteremia. Interestingly, neutro-
phils are endowed with effector mechanisms termed neutrophil
extracellular traps (NETs, large webs of decondensed chromatin
coated with granule proteins) that are expelled from activated
neutrophils that can capture and kill microbes in the extracel-
lular space (Brinkmann et al., 2004; Papayannopoulos and
Zychlinsky, 2009). Despite a paucity of in vivo evidence about
the roles of NETs in host defense, NETs have been observed
within tissues such as the skin and lungs, where they contribute
to the containment of acute bacterial infections in animal models
of cellulitis, necrotizing faciitis, and pneumonia (Beiter et al.,
2006; Buchanan et al., 2006; Li et al., 2010). However, no studies
have directly observed the formation of NETs within the vascula-
ture in vivo, nor investigated their ability to capture bacteria from
the bloodstream. Using an in vitro flow chamber assay, we have
previously reported that NETs are stably produced and cansevier Inc.
Figure 1. Intravascular NETs Are Released in Liver Sinusoids during
Endotoxemia
(A) SD-IVM of the liver revealed intravascular NETs consisting of DNA (green),
histones (H2Ax, red), and granule proteins (neutrophil elastase, blue). The
scale bar represents 10 mm.
(B) Representative series of SD-IVM images from the liver of an LPS-treated
mouse in which DNA was stained with sytox green (green), followed by i.v.
infusion of DNase (2000 U) demonstrating digestion of the intravascular DNA at
various time points after DNase injection. The scale bar represents 25 mm.
(C) Representative SD-IVM image of the liver of an LPS-treated mouse
demonstrating intravascular neutrophils (green) and extensive sinusoidal
coverage by NETs (histone H2Ax, red). The scale bar represents 50 mm.
(D) Quantitative analysis of NETs within the livers of mice treated with control
IgG (control) or high-dose anti-Gr1 (neutrophil depleted) prior to administration
of LPS. Data are shown as mean ± SEM. ***p < 0.001 versus untreated,
**p < 0.01, NS = not significant; n = 3–6 mice per group.
See also Figure S1 and Movie S1.
Cell Host & Microbe
Intravascular NETs Capture Circulating Bacteriaensnare bacteria under flow conditions that simulate the hemo-
dynamics of liver sinusoids (Clark et al., 2007). However, it
remains unknownwhether NETs can be formedwithin the vascu-
lature and whether they contribute to intravascular immunity
during septic infections.
Herein, we hypothesize that neutrophils recruited to liver
sinusoids during bacterial sepsis cast NETs to ensnare circu-
lating bacteria and protect against hematogenous dissemination
of infections. Using dual laser multichannel spinning-disk
microscopy for in vivo imaging, we observed the presence of
intravascular NETs within liver sinusoids in endotoxemic and
septic mice and found that these structures increased the
capture of circulating E. coli by 4-fold. Furthermore, we demon-
strate that intravascular NETs production in response to LPS or
E. coli sepsis is regulated by b2-integrin-dependent platelet-
neutrophil interactions within sinusoids and that disruption of
NET production by inhibition of platelet-neutrophil interactionsCell Host & Mleads to defective clearance of E. coli by the liver and enhanced
dissemination to distant organs. Together, our data demonstrate
that neutrophils migrate to liver sinusoids during sepsis where
they cast NETs into the bloodstream to protect against the
spread of bacteria.
RESULTS
Neutrophil Extracellular Traps AreReleasedwithin Liver
Sinusoids during Endotoxemia
Multichannel spinning-disk intravital microscopy was used to
visualize the liver microvasculature of endotoxemic mice four
hours after the administration of 1 mg/kg LPS. To probe for the
presence of extracellular DNA within the liver vasculature, we
intravenously infused the cell-impermeable DNA dye Sytox
Green, revealing the presence of web-like DNA structures within
the lumens of sinusoids (Figure 1A) that were not present in
untreated animals or LPS-treated mice that were depleted of
neutrophils (Figure S1 available online). Dissolution of the Sytox
Green fluorescence staining within seconds of intravenous
injection of DNase verified that the intravascular webs were
composed of extracellular DNA (Figure 1B and Movie S1,
part A). To confirm that these extracellular webs of DNA were
in fact NETs (defined by the presence of extracellular chro-
matin laden with neutrophil granule proteins), we intravenously
infused fluorescently labeled antibodies specific for histone
H2Ax (red) and neutrophil elastase (blue) and demonstrated
colocalization of these NET-defining markers (Figure 1A and
Movie S1, part B).
The most stable and robust staining of NETs was achieved
with Alexa-fluor 555 labeled anti-histone H2Ax antibody, and
this was therefore chosen as the representative NET marker for
subsequent experiments. Indeed, NETs (as revealed by histone
H2Ax staining) were observed stably attached to the vessel walls
throughout the slow-flowing liver sinusoids (Figure 1C), but not
within the larger and higher shear venules (data not shown).
Quantification of the area (per field of view) covered by NETs
staining within the liver confirmed a significant increase in
histone H2Ax staining 4 hr after the induction of endotoxemia
in control animals (treated with 200 mg control IgG 24 hr prior
to LPS), but was not increased above baseline in animals that
were depleted of neutrophils (by administration of 200 mg anti-
Gr1 antibody 24 hr prior to LPS) (Figure 1D), confirming that
neutrophils are the source of NETs within liver sinusoids during
endotoxemia.
Release of Intravascular NETs Is Dependent
on Platelet-Neutrophil Interactions
We have previously reported that human neutrophils release
NETs in vitro under flow conditions in response to interactions
with TLR4-activated platelets (Clark et al., 2007). We hypothe-
sized that a similar collaboration between platelets and neu-
trophils regulated NETs release within liver sinusoids of mice.
To test this hypothesis, we visualized the interactions between
platelets and neutrophils within the liver in vivo using spinning-
disk confocal intravital microscopy (SD-IVM). In response to
endotoxemia, neutrophils adhered to the endothelium in sinu-
soids, and platelets subsequently docked onto the surface of
neutrophils, coating them with large aggregates of plateletsicrobe 12, 324–333, September 13, 2012 ª2012 Elsevier Inc. 325
Figure 2. NETs Release in Liver Sinusoids Is
Dependent on LFA-1-Mediated Platelet-
Neutrophil Interactions
(A) Representative SD-IVM images of liver sinu-
soids in LPS-treated mice that were pretreated
(24 hr prior) with control serum (i, LPS control),
platelet-depleting serum (ii, LPS PLT depl), or
high-dose neutrophil-depleting anti-Gr1 (iii, LPS
PMN depl). Neutrophils shown in green (Gr-1),
platelets in blue (CD49b). The scale bar represents
50 mm.
(B and C) Quantitative analysis of platelet adhe-
sion (per field of view) (B) and NETs (C) within the
livers of mice that were treated with control serum
(control) or platelet-depleting serum (platelet
depleted) prior to administration of LPS.
(D and E) 3D renderings of z stack SD-IVM images
of liver sinusoids in LPS-treated wild-type (E, WT)
and LFA-1 deficient (F, LFA-1/) mice. Neutro-
phils are shown in green (Gr-1), NETs are shown in
red (histone H2Ax), and platelets are shown in blue
(CD49b). The scale bar represents 25 mm.
(F andG) Quantitative analysis of platelet adhesion
(F) and NETs (per field of view) (G) within the liver
sinusoids of wild-type (WT) and LFA-1 deficient
(LFA-1/) mice left untreated or treated with LPS
4 hr prior to imaging. Data are shown as mean ±
SEM. ***p < 0.001 versus untreated, **p < 0.01,
*p < 0.05; n = 3–6 mice per group.
See also Figure S2 and Movie S2.
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of platelets with anti-thrombocyte serum completely eliminated
the appearance of platelets in liver sinusoids compared to
control serum-treated mice without affecting the numbers of
adherent neutrophils (Figures 2Aii, 2B, and S2A). Furthermore,
there was no increase in the amount of adherent platelets within
the liver sinusoids after LPS administration in animals that
were depleted of neutrophils, confirming that the accumulation
of platelets within liver sinusoids required adherent neutrophils
(Figure 2Aiii, 2B, and S2A). Finally, prevention of platelet-
neutrophil interactions by depletion of platelets (or neutrophils
as shown above) prevented the release of NETs within sinusoids
(Figure 2C). Therefore, adherent neutrophils release NETs within
the liver vasculature during endotoxemia in response to interac-
tions with platelets.
We have previously reported that platelets bind to neutrophils
in response to LPS via b2-integrin (CD18) in sinusoids (Jenne
et al., 2011). Consistent with these observations, we observed326 Cell Host & Microbe 12, 324–333, September 13, 2012 ª2012 Elsevier Inc.reduced platelet accumulation in liver
sinusoids of mice deficient of the aLb2-
integrin LFA-1 (CD11a/CD18) compared
to their WT counterparts (Figures 2D–2F
and Movie S2, part C). Importantly, defi-
ciency of LFA-1 did not affect the number
of neutrophils that adhered within liver
sinusoids in response to LPS (Figures
S2B–S2D). Similar to platelet depletion,
blocking platelet-neutrophil interactions
in LFA-1 deficient mice reduced the
quantity of NETs within the liver sinusoidsafter LPS administration compared to their WT counterparts
(Figures 2D, 2E, and 2G and Movie S2, part C).
HumanNeutrophils Release NETs in Response to LFA-1-
Mediated Platelet-Neutrophil Interactions
To determine whether our findings in the mouse system trans-
lated to human cells, we investigated the binding interactions
between human platelets and neutrophils under physiologic
flow conditions in vitro. In brief, human neutrophils were isolated
from healthy donors and were immobilized on the surface of an
in vitro parallel-plate flow chamber. Next, isolated human plate-
lets were perfused across the neutrophil monolayer, and their
binding to immobilized neutrophils was quantified. Perfusion of
unstimulated platelets over a neutrophil monolayer resulted in
very few platelet-neutrophil interactions (Figure 3A). In contrast,
platelets stimulated with LPS bound abundantly to immobilized
neutrophils (Figure 3A). Consistent with our findings in themouse
system presented above, blocking LFA-1 with a neutralizing
Figure 3. Release of NETs under Flow Conditions by Human
Neutrophils Is Dependent on LFA-1-Mediated Platelet-Neutrophil
Interactions
(A and B) Adhesion of human platelets (A) left untreated or treated with LPS
(A) or treated with plasma from healthy donors or from severely septic patients
(B) to immobilized neutrophils in an in vitro parallel plate flow chamber. LFA-1
was blocked with anti-CD11a F(ab)2.
(C–F) Representative images from flow chamber experiments in which
untreated (C and D) or LPS-treated (E andF) platelets were perfused across
neutrophil monolayers and the release of NETs was visualized with Sytox
Green DNA dye.
(G) Quantification of NETs release after perfusion of untreated or LPS-treated
platelets across neutrophil monolayers. LFA-1 was blocked with anti-CD11a
F(ab)2. Data are expressed as total area (mm
2) covered by NETs per field of
view over 10 min of imaging (area under the curve [AUC] of area versus time
plot). Data are shown as mean ± SEM. **p < 0.01 versus untreated, *p < 0.05;
n = 3–4 individual experiments.
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Cell Host & Manti-LFA-1 F(ab)2 completely prevented LPS-induced binding
between human platelets and neutrophils under flow conditions
(Figure 3A).
Next, we investigated whether LFA-1 mediated platelet-
neutrophil interactions occurred in human sepsis. Platelets
stimulated with plasma from severely septic patients bound to
immobilized neutrophils in significantly higher numbers com-
pared to platelets incubated with plasma from healthy volun-
teers (Figure 3B). Furthermore, neutralization of LFA-1 reduced
platelet-neutrophil interactions in response to plasma from
severely septic patients to levels seen with healthy patient
plasma (Figure 3B).
Finally, to determine whether human neutrophils generate
NETs in response to LFA-1-mediated platelet-neutrophil interac-
tions, we quantified NETs formation in vitro under flow con-
ditions. Indeed, perfusion of LPS-stimulated platelets over
immobilized neutrophils resulted increased platelet-neutrophil
interactions (shown above) as well as significantly in-
creased NETs release compared to untreated platelets (Figures
3C–3G), and this could be entirely prevented by the addition of
anti-LFA-1 F(ab)2 (Figure 3G).
Intravascular NETs Ensnare Bacteria from the
Bloodstream
To test the hypothesis that intravascular NETs function to
capture bacteria from the circulation in vivo, we intravenously
infused fluorescently labeled E. coli intomice and visualized their
capture within the liver microvasculature with SD-IVM. In non-
inflamed mice (no neutrophils present in sinusoids), bacterial
capture is mediated entirely by resident intravascular macro-
phages (Kupffer cells) (Lee et al., 2010). Within untreated (non-
inflamed) animals, Kupffer cells captured 27.1 ± 3.1 bacteria
per field of view (Figure 4A and Movie S3, part A). Strikingly,
LPS-treated animals (in which neutrophils are recruited to the
liver and NETs are released) ensnared 4-times more bacteria
(103.5 ± 8.2 bacterial per field) within liver sinusoids compared
to untreated controls (Figure 4A and Movie S3, part A). Further-
more, total depletion of neutrophils significantly reduced bacte-
rial trapping compared to endotoxemic control mice (Figure 4A
and Movie S3, part A). In addition, disruption of intravascular
NETs with i.v. DNase administration reduced the quantity of
bacteria trapped within liver sinusoids during endotoxemia (Fig-
ure 4A). In these experiments, DNase was administered as
a single dose pretreatment (rather than multiple doses after the
onset of inflammation), possibly accounting for the subtotal
reduction in bacterial trapping. Importantly, DNase adminis-
tration did not reduce the number of adherent neutrophils in
sinusoids (Figure S3). Visualization of bacterial trapping within
sinusoids revealed that fluorescent E. coli became immobilized
intravascularly in areas that were rich in NETs (indicated by
histone H2Ax staining), providing further evidence that intravas-
cular NETs capture circulating E. coli (Figure 4B and Movie S3,
part B).
The contribution of NETs to bacterial trapping in the inflamed
sinusoids was further investigated after blockade of NETs re-
lease by preventing platelet-neutrophil interactions. Importantly,
blockade of platelet-neutrophil interactions prevents NETs
release without reducing the number of adherent neutrophils in
sinusoids (shown above). Endotoxemic platelet-depleted miceicrobe 12, 324–333, September 13, 2012 ª2012 Elsevier Inc. 327
Figure 4. Intravascular NETs Enhance Trap-
ping of Circulating Bacteria
(A) Four hours after administration of LPS, mice
were infused i.v. with 1 3 107 CFU fluorescently
labeled E. coli. SD-IVM was used to determine the
numbers of trapped bacteria within liver sinusoids
per field of view at the indicated time points.
Neutrophil-depleted mice (PMN-depleted + LPS)
and DNase-treated mice (DNase + LPS) were
compared control IgG-treated mice (control +
LPS) and untreated negative controls (no LPS, UT).
(B) 3D rendering of z stack SD-IVM image
demonstrating E. coli (SYTO 60, blue) trapped in
a NET (H2Ax, red) released by a neutrophil (Gr-1,
green) within a sinusoid in an LPS-treated mouse.
The scale bar represents 10 mm.
(C and D) The numbers of trapped E. coli was
determined as described above in (C) platelet-
depleted (PLT-depleted + LPS) versus control-
serum treated (control + LPS) mice (C) and wild-
type (WT+LPS) versusLFA-1deficient (LFA-1/+
LPS) mice (D). Data are shown as mean ± SEM.
**p < 0.01; n = 3–6 mice per treatment group.
See also Figure S3 and Movie S3.
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E. coli in sinusoids compared to mice treated with control serum
(Figure 4C). Likewise, disruption of platelet-neutrophil interac-
tions in LFA-1-deficient mice caused significantly reduced trap-
ping of E. coli compared to wild-type animals (Figure 4D). Taken
together, these results suggest that liver-infiltrating neutrophils
enhance the clearance of bacteria from the bloodstream through
the release of intravascular NETs.
Intravascular NETs Protect against Bacterial
Dissemination in E. coli-Induced Sepsis
To understand the role of intravascular NETs during a bona fide
septic bacterial infection, mice were infected intraperitoneally
with 1 3 107 colony forming units (CFU) of E. coli. At 4 hr after
E. coli infection, neutrophils were recruited to the liver, and
profound platelet-neutrophil interactions were observed (Figures
5A and 5B). In addition, intravascular NETs were detected within
sinusoids (Figure 5C). Furthermore, consistent with our results
from the endotoxemia experiments above, platelet-neutrophil
interactions and NETs production were reduced in LFA-1/
mice at 4 hr after infection (Figures 5A–5C).
Given that NETs were generated during the acute phase of
sepsis, we studied the dissemination of E. coli during the first
24 hr after intraperitoneal (i.p.) infection. To test our hypothesis
that intravascular NETs in the liver protect against bacterial
dissemination, we investigated the hematogenous spread of
bacteria and the resultant dissemination of the infection to
distant organs (the lungs). Disruption of intravascular NETs by
depletion of platelets or intravenous administration of DNase re-
sulted in profoundly elevated bacteremia compared to control
animals at 6 hr after infection (Figure 6A). At 24 hr after infection,
E. coliCFU in lung tissuewere significantly elevated compared to
control mice, indicating profound dissemination of infection (Fig-
ure 6B). It should be noted that no experimental groups showed
a difference in bacterial load within the peritoneum (site of infec-
tion, not shown). Finally, LFA-1-deficient mice showed signifi-
cantly higher bacterial burden in the blood at 6 hr and increased328 Cell Host & Microbe 12, 324–333, September 13, 2012 ª2012 Elbacteria in the lungs at 24 hr (p = 0.056) compared toWT controls
(Figures 6C and 6D). These results indicate that blocking NETs
release (by platelet depletion or LFA-1 deficiency) or degradation
of the DNA backbone of NETs (by intravenous [i.v.] DNase)
impairs host defenses against bacterial dissemination during
Gram-negative sepsis.
Intravascular NETs Cause Collateral Liver Damage
during E. coli-Induced Sepsis
NETs have been implicated in immune-mediated tissue damage
in a number of diseases including endotoxemia (Clark et al.,
2007; Papayannopoulos and Zychlinsky, 2009). Twenty-four
hours after the onset of E. coli-induced sepsis, serum levels of
alanine aminotransferase (ALT, a marker of hepatocellular
damage) were significantly increased compared to untreated
(nonseptic) animals, but not in platelet-depleted or DNase-
treated mice (Figure 7A). Similarly, LFA-1/ mice displayed no
increase in serum ALT levels compared to untreated (nonseptic)
control (Figure 7B). Furthermore, histological examination of liver
tissue from septic animals revealed marked pathology including
patchy necrosis and sinusoidal congestion (Figure 7C). How-
ever, these areas of patchy necrosis were not observed in liver
tissue recovered from septic animals in which NETs were
reduced/eliminated (DNase-treated, platelet-depleted, and
LFA-1-deficient) (Figures 7D–7F). Clearly, the production of
NETs within sinusoids helps to increase bacterial trapping, yet
this occurs at the expense of damage to the liver.
DISCUSSION
This study reports a number advancements in our understanding
of NETs biology in host defense, including the demonstration
that NETs are generated within the vasculature in vivo during
sepsis and that intravascular NETs contribute to host defense
during bacterial sepsis (albeit, at the expense of tissue damage
and organ dysfunction). Furthermore, this study expands on
previous investigations of the mechanisms of NETs productionsevier Inc.
Figure 5. Platelet-Neutrophil Interactions and NETs Release Are
Dependent on LFA-1 during Gram-Negative Sepsis
At 4 and 24 hr after i.p. infection with 1 3 107 CFU E. coli, wild-type (WT) and
LFA-1-deficient (LFA-1/) animals were imagedwith SD-IVM to determine the
numbers of adherent neutrophils (per 203 field) (A), the quantity of adherent
platelets (per 203 field) (B), and the quantity of NETs released within liver
sinusoids (per 203 field) (C). Data are shown as mean ± SEM. *p < 0.05; n = 5
mice per treatment group.
Figure 6. Disruption of Intravascular NETs in Liver Sinusoids Causes
Enhanced Bacterial Dissemination during Gram-Negative Sepsis
(A and B) Six hours after the onset of intraperitoneal E. coli infection, blood was
harvested for the determination of bacterial loads in the bloodstream (CFU/ml).
Twenty-four hours after the onset of infection, lung tissues was harvested to
assess the extent of bacterial dissemination to the lungs (CFU/g tissue).
Bacterial loads in the blood (A) and lungs (B) of mice that were pretreated (prior
to infection) with control serum (control), platelet-depleting serum (PLT-
depleted), or DNase (administered i.v. at time 0 and 4 hr after infection in A, and
0 and 10 hr after infection in B).
(C and D) Bacterial loads in the blood (C) and lungs (D) of wild-type (WT) versus
LFA-1-deficient (LFA-1/) mice.
Data are shown as mean ± SEM. ***p < 0.001, *p < 0.05; n = 5–9 mice per
treatment group in (A) and (C), and n = 11 mice in (B) and (D).
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that intravascular NET release is activated by LFA-1 mediated
platelet-neutrophil interactions in both murine and human
sepsis. The results presented in this study provide insight into
NETs biology in host defense and disease pathogenesis in
bacterial sepsis.
In this study, we provide evidence that neutrophil recruitment
to the liver during Gram-negative sepsis is a coordinated host
defense mechanism that protects against microbial dissemina-
tion through the production of intravascular NETs. We have
observed a similar intravascular NET response in the liver
(involving platelet-neutrophil interactions) during Gram-positive
sepsis induced by Staphylococcus aureus or during viral infec-
tion (data not shown), suggesting that this intravascular host
defense mechanism may be deployed in response to a variety
of pathogens. Unlike many other organs in which neutrophils
are recruited primarily in postcapillary venules, the overwhelming
majority of neutrophils recruited to the liver during endotoxemia/
sepsis adhere within the capillary-like sinusoids. Furthermore,
the majority of neutrophils that arrest within sinusoids remainCell Host & Mwithin the intravascular compartment attached to the sinusoidal
endothelium (McDonald et al., 2008; Menezes et al., 2009). As
such, neutrophils recruited to the septic liver are optimally posi-
tioned to mount an intravascular host response to combat
bacteremia. This intravascular defense system appears to be
well positioned in an organ that receives a significant proportion
of the cardiac output as well as the portal venous drainage of the
gut. This intravascular barrier may be particularly relevant in
septic shock when changes in gut barrier function enable the
translocation of intestinal microbes into the blood (Doig et al.,
1998). Therefore, in addition to combating the hematogenous
dissemination of the primary infection, intravascular NETs within
the liver may also limit infections by gut microbes during sepsis.
Within the neutrophil’s arsenal of anti-microbial effector mech-
anisms, NETs represent one of the more efficient means of
capturing and killing bacteria (Brinkmann et al., 2004). The quan-
tity of bacteria that can be captured by receptor-dependent
mechanisms and internalized by phagocytosis is limited by the
surface area of the leukocyte, its position within the vasculature,
andthe efficiency of receptor-mediated trapping. NETs may
form large extracellular webs even under flow conditions within
liver sinusoids. Indeed, we observed that the coverage oficrobe 12, 324–333, September 13, 2012 ª2012 Elsevier Inc. 329
Figure 7. Disruption of Intravascular NETs in Liver Sinusoids
Prevents Liver Damage in Gram-Negative Sepsis
(A and B) Twenty-four hours after the onset of i.p. E. coli infection, serum ALT
levels were measured in untreated control (no infection) (A) and septic (B) mice
that were pretreated (prior to infection) with control serum (control), platelet-
depleting serum (PLT-depl), or DNase (administered i.v. at time 0 and 10 hr
after infection), as well as wild-type (WT) versus LFA-1 deficient (LFA-1/)
mice (B). Data are shown as mean ± SEM. ***p < 0.001; n = 11 mice per
treatment group.
(C–F) Representative fields of view from hematoxylin and eosin-stained liver
tissue sections from control serum (control) (C), platelet-depleting serum (PLT-
depl) (D), DNase-treated (administered i.v. at time 0 and 10 hr afterinfection)
(E), and LFA-1 deficient (LFA-1/) (F) mice harvest 24 hr after the onset of
E. coli infection. Scale bars represent 250 mm (43) and 100 mm (103).
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NETs were cast within nearly every sinusoid, even extending into
areas distant from the nearest neutrophil. Furthermore, in the
absence of NETs release, the mere presence of neutrophils
in sinusoids did not substantially augment bacterial capture,330 Cell Host & Microbe 12, 324–333, September 13, 2012 ª2012 Elindicating that receptor-mediated trapping is not an important
mechanism for bacterial capture by neutrophil within the vascu-
lature. Indeed, direct observation of E. coli capture by intravital
microscopy revealed that bacteria were rarely captured at the
neutrophil surface, but were ensnared within extracellular NETs
often at a distance from any adherent neutrophil. In contrast
to neutrophils, Kupffer cells capture circulating bacteria upon
their surface using unique receptors such as the complement
receptor for Ig (CRIg), which is not expressed by neutrophils
(Helmy et al., 2006). In the absence of neutrophils (neutrophil-
depleted animals), the administration of LPS did not further
increase the amount of bacteria captured by Kupffer cells. This
observation indicates that the release of NETs by neutrophils
within sinusoids represents a mechanism for upregulation of
bacterial trapping capacity when Kupffer cells are overwhelmed.
After capture, it is possible that NETs may kill ensnared bacteria
directly, or they may simply immobilize pathogens for subse-
quent phagocytosis by neutrophils, Kupffer cells, or infiltrating
monocytes.
The release of NETs by neutrophils within liver sinusoids was
found to be dependent on interactions between adherent
neutrophils and platelets. Best known for their roles in hemo-
stasis, platelets are also active contributors to multiple immuno-
logical processes (Semple et al., 2011). In vitro, engagement
between adherent neutrophils and activated platelets (stimu-
lated with LPS or plasma from septic patients) was shown
to initiate NET release through b2-integrin mediated platelet-
neutrophil engagement. The molecular mechanism of communi-
cation between activated platelets and neutrophils has yet to be
elucidated, but from our in vitro and in vivo data, it is clear that
contact between platelets and neutrophils is critical for NETs
production. The requirement for integrin-mediated adhesion
between neutrophils and platelets suggests that NET release
requires not only the presence of platelets in sinusoids, but
direct binding between these cells within the vasculature. The
adhesion molecule-dependent binding may facilitate contact-
mediated signaling and/or establish sufficient proximity for
transmission of paracrine mediators from activated platelets to
neutrophils.
In addition to aiding in host defense against bacterial dis-
semination, our results clearly indicate that intravascular NETs
contribute substantially to liver pathology during bacterial
sepsis. Disruption of NETs in septic mice by platelet depletion,
blockade of platelet-neutrophil interactions (in LFA-1/ mice),
or intravenous infusion of DNase prevented the elevation of
serum ALT levels and liver histopathology. Numerous reports
have demonstrated roles for NETs in tissue damage and disease
pathology in a number of infectious, inflammatory, and autoim-
mune diseases (Clark et al., 2007; Fuchs et al., 2010; Kessen-
brock et al., 2009; Villanueva et al., 2011). Within the septic liver,
NETs may contribute to tissue damage in multiple ways. Neutro-
phil serine proteases have recently been shown to activate coag-
ulation in vivo, including within liver sinusoids, ultimately leading
to vascular occlusion (Massberg et al., 2010). NETs are deco-
ratedwith serine proteases, and the resulting intravascular coag-
ulation may contribute to hypoperfusion and ischemic tissue
injury. In addition, there is mounting evidence that other compo-
nents of NETs such as histones may be central to the function of
NETs in both immunity and disease pathogenesis. In particular,sevier Inc.
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directly cytopathic to endothelial cells in vitro and that immuno-
neutralization of histones in vivo reduced organ damage and
enhanced survival in animal models of sepsis and endotoxemia
(Xu et al., 2009). Furthermore, these authors demonstrated that
recombinant activated protein C (rAPC) cleaves histones and
neutralizes their cytopathic activity, yielding a putative link
between NET components and the protective effect of the only
targeted therapy available for the treatment of severe sepsis
(that is, rAPC). The exact source of pathological histones in their
models of sepsis was not defined, but a recent study by Saffar-
zadeh and colleagues suggests that NETs may be an important
source of extracellular histones that mediate tissue injury (Saffar-
zadeh et al., 2012; Chaput and Zychlinsky, 2009).
Although it has been postulated that targeting NETs therapeu-
tically may reduce disease pathology and mortality associated
with severe sepsis, our study provides evidence that disrupting
NETs critically impairs host defenses and allows for bacteria to
spread throughout the body. Nevertheless, effective control of
bacterial infections with antibiotics may make it possible to ther-
apeutically target NETs to reduce disease pathology without the
risk of bacterial dissemination. Indeed, therapeutic neutralization
of histones improved survival in mice with polymicrobial sepsis
only when coadministered with antibiotics (Xu et al., 2009).
Therefore, the critical antimicrobial role of NETs during severe
sepsis may be successfully overcome by antibiotic coverage,
allowing for therapeutic targeting of NETs to reduce organ
damage in severe sepsis.
EXPERIMENTAL PROCEDURES
Mice
C57Bl/6J mice were purchased from Jackson Laboratories (Bar Harbor, ME).
LFA-1-deficient mice (Itgal/) on a C57Bl/6J background were a gift from
Dr. Ballantyne (Baylor College of Medicine, TX). Animals were maintained in
a specific pathogen-free environment at the University of Calgary Animal
Resource Centre. All experimental animal protocols were approved by the
University of Calgary Animal Care Committee and were in compliance with
the Canadian Council for Animal Care Guidelines.
Antibodies and Reagents
Sytox Green DNA dye and Alexa-fluor protein labeling kits were purchased
from Invitrogen. DNase was purchased from Roche. Alexa-fluor 488-labeled
and unconjugated anti-Gr-1 antibodies were purchased from UBC ABlab
(Vancouver, BC, Canada). Goat anti-mouse histone H2Ax and goat anti-
mouse neutrophil elastase antibodies were purchased from Santa Cruz
Biotechnology. Alexa-fluor 647-labeled anti-mouse CD49b was purchased
from Biolegend. Spleen and thymocyte adsorbed anti-mouse thrombocyte
(platelet depleting) serum and normal rabbit serum (control), as well as rat
IgG control antibody, were purchased from Cedarlane Labs (Hornby, ON,
Canada). Unconjugated antibodies used for fluorescence imaging experi-
ments were labeled with Alexa-fluor protein labeling kits from Invitrogen
according to the manufacturer’s instructions. Anti-human LFA-1 (CD11a)
was purchased from Calbiochem.
Spinning Disk Confocal Intravital Microscopy
Mice were anesthetized with a mixture of ketamine hydrochloride (200 mg/kg,
Rogar/SBT) and xylazine hydrochloride (10 mg/kg, MTC Pharmaceuticals).
After anesthesia, cannulation of the right jugular vein was performed for admin-
istration of additional anesthetic and for injection of antibodies or other
reagents. Preparation for intravital imaging of the liver was performed as previ-
ously described (McDonald et al., 2008). The exposed liver lobe was visualized
with an Olympus IX81 invertedmicroscope equipped with a confocal light pathCell Host & M(Wave-Fx; Quorum) based on a modified Yokogawa CSU-10 head (Yokogawa
Electric Corporation) with a UPLANSAPO 103/0.40 or UPLANSAPO 203/0.70
air objective. Three laser excitation wavelengths (488, 561, and 635 nm;
Cobalt) were used in rapid succession and visualized with the appropriate
long-pass filters (Semrock). Exposure times for excitation wavelengths were
303 ms (488 nm), 303 ms (561 nm), and 300 ms (635 nm). A back-thinned
EMCCD 512 3 512 pixel camera (C9100-13, Hamamatsu, Bridgewater, NJ)
was used for fluorescence detection. Volocity acquisition software (Improvi-
sion) was used to drive the microscope.
Image Analysis
Fluorescence imaging of NETs components was performed with intravital
immunofluorescence analysis. Extracellular DNA was labeled with Sytox
Green DNA dye (5 mM), histone H2Ax was labeled with Alexa-fluor 555-anti-
mouse H2Ax antibody (5 mg), and neutrophil elastase (NE) was labeled with
Alexa-fluor 647-anti-mouse NE antibody (0.6 mg). Platelets were visualized
by injection of Alexa-fluor 647-anti-mouse CD49b antibody (4 mg), and neutro-
phils were visualized by injection of Alexa-fluor 488-anti-mouse Gr-1 antibody
(3 mg). All antibodies and dyes were injected i.v. 15 min prior to intravital
imaging. Platelets and NETs were quantified with SD-IVM using previously
published methodology (Jenne et al., 2011). In brief, images were acquired
as z stacks of xy planes (1 mm intervals) from the bottom to top of sinusoids
in each field of view using a 203 objective lens, and saved as extended focus
images in .tiff format. Images from individual color channels (e.g., red for
histone H2Ax, far red for platelets) were exported and analyzed in ImageJ
(NIH). So that differences in background fluorescence between experiments
and antibody lots could be accounted for and background autofluorescence
could be eliminated, contrast was adjusted to minimize autofluorescent
background staining, and a minimum brightness threshold was set to yield
only positive staining. The same contrast and threshold values were applied
to all images from all treatment groups within the experiment. Thresholded
images were converted to binary (black and white), and the area per field of
view covered by positive fluorescence staining (black) was calculated with
ImageJ software. Data are expressed as the percentage of area in each field
of view covered by positive fluorescence staining.
Experimental Protocols
Mice were treated with an intraperitoneal injection of 1 mg/kg purified LPS
from E. coli 0111:B4 (List Biologicals) 4 hr prior to intravital microscopy. The
dose of LPS used in this study was sufficiently low that animals survived
anesthesia and hepatic perfusion was not severely diminished. The purity of
the commercial LPS was confirmed by inoculation into TLR4 knockout
(TLR4/) animals and observation of no measurable response in any of the
parameters reported in this study (data not shown). For platelet depletion
experiments, mice were injected i.p. with 50 ml anti-mouse thrombocyte serum
or 50 ml control serum (adsorbed normal rabbit serum) 24 hr prior to LPS
administration or E. coli infection. For neutrophil depletion experiments,
mice were injected i.p. with 200 mg anti-Gr-1 antibody or 200 mg rat IgG control
antibody 24 hr prior to LPS administration. Platelet and neutrophil depletion
were confirmed with SD-IVM (see Figure 2). In some experiments, mice were
treated with 2000 U DNase intravenously at various time points after infection
with E. coli (noted in the figure legends).
In Vivo Bacterial Trapping Assay
Bacterial trapping within the liver sinusoids was quantified by direct visualiza-
tion with intravital microscopy as described previously (Clark et al., 2007).
E. coli (Xen14, Caliper Life Sciences) grown to mid-log phase in LB-kanamycin
broth were labeled with 2.5 mM Syto60 dye. Mice were prepared for liver intra-
vital microscopy as described above, and 13 107 CFU of fluorescently labeled
E. coli were infused intravenously via the jugular vein cannula. The liver was
then visualized using SD-IVM with a 103 objective, and the numbers of
trapped bacteria were counted per field of view at times 0, 10, and 20min after
infection.
E. coli Sepsis Model and Bacterial Dissemination
Micewere infected intraperitoneally with 13 107CFU of Escherichia coli (strain
Xen14) grown to mid-log phase in LB-kanamycin broth. At 6 or 24 hr after
infection, animals were euthanized under anesthesia, and the lungs and bloodicrobe 12, 324–333, September 13, 2012 ª2012 Elsevier Inc. 331
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tissue homogenizer. Serial dilutions of lung homogenates or blood were plated
on LB agar plates containing kanamycin (30 mg/ml). Plates were incubated at
37C overnight, and CFU were counted.
Biochemical Assessment of Liver Injury
Serum levels of alanine aminotransferase (ALT) were detected in blood ob-
tained via cardiac puncture as an indicator of hepatocellular injury. A commer-
cially available diagnostic kit (Biotron Diagnostic) was used to quantify serum
levels of ALT. Results are expressed as International Units per liter of serum.
Liver Histology
The left liver lobe was harvested from experimental animals and placed in 10%
neutral buffered formalin (Sigma-Aldrich). The formalin-fixed tissue was then
embedded in paraffin, cut in 4 mm sections, and stained with hematoxylin
and eosin by Calgary Laboratory Services.
Human Platelet and Neutrophil Isolation
Whole blood was obtained from healthy donors in acid citrate dextrose (ACD).
For neutrophil isolation, erythrocytes were removed by dextran sedimentation
to obtain leukocyte-rich plasma, and residual erythrocytes were removed by
two rounds of hypotonic lysis with ddH2O. Neutrophils were separated from
other leukocytes by density gradient centrifugation with Ficoll-Histopaque.
For platelet isolation, platelet-rich plasma was filtered through a sepharose
2B column. In some experiments platelets were fluorescently labeled with Cal-
cein AM (Invitrogen).
Generation of F(ab’)2 fragments
F(ab’)2 fragments were generated with isotype-specific kits (Thermo Scientific
Pierce). Immobilized pepsin proteases were used as per manufacturer’s
instructions to digest whole IgG molecules. The recovery of a pure fraction
of F(ab’)2 fragments was performed by elution through protein A to remove
Fc and undigested fragments.
Patient Samples
Plasma from severely septic adult patients (APACHE scoresR 25 points) was
obtained through the Critical Care Epidemiologic and Biologic Tissue
Resource (CCEPTR) facility at the University of Calgary. Informed consent
was provided by patients or their representatives, and this studywas approved
by the University of Calgary research ethics committee. Sample selection
was based on clinical inclusion/exclusion criteria previously published by
our laboratory (Ibbotson et al., 2001). Patients with human immunodeficiency
infection and patients treated with chemotherapeutic agents or rAPC were
excluded.
Parallel Plate Flow Chamber Assay
The procedure for the flow chamber assay was performed as previously pub-
lished by our laboratory (Clark et al., 2007). In brief, chamber coverslips were
coated with plasma from the neutrophil donor and were subsequently coated
with isolated neutrophils (200 ml 1 3 107 cells/ml). Assembled flow chambers
were placed on a Zeiss Axiovert 25 microscope equipped with a heated enclo-
sure maintained at 37C. Fluorescently labeled platelets (53 107cells/ml) were
incubated for 30 min at 37C in the presence of 10% plasma (from the platelet
donor) ± LPS (5 mg/ml) and were then perfused through the flow chamber over
immobilized neutrophils at a rate of 0.5 ml/min (shear force of 1 dyne/cm2) for
10 min. In experiments using plasma from septic patients, platelets were incu-
bated with 10% patient plasma for 30 min at 37C. In some experiments,
neutrophils were incubated with anti-LFA-1 F(ab’)2 fragments for 10 min prior
to platelet perfusion. Platelet-neutrophil interactions were visualized with
a CCD camera (C2400; Hamamatsu), and the images were recorded with
a DVD recorder for playback analysis. Platelet adhesion to neutrophils was as-
sessed by counting the number of fluorescent platelets that bound to neutro-
phils for R 10 s over a 10 min interval. Data are expressed as the number of
adherent platelets per 100 neutrophils over 10 min.
Quantification of NETs In Vitro under Flow Conditions
Visualization of NET formation under flow conditions was performed with the
Bioptechs FCS2 parallel plate flow chamber. Experiments were performed as332 Cell Host & Microbe 12, 324–333, September 13, 2012 ª2012 Eldescribed above, with the slight modification of a higher neutrophil con-
centration (2 3 107 cells/ml), and the addition of nucleic acid stain Sytox
green (0.3mM, Invitrogen). In some experiments, DNase I (1000 U/ml,
AppliChem) was added to digest extracellular DNA. Dynamic NETs release
under flow was visualized with a laser-scanning microscope equipped with
a 203/0.75 NA air objective (Olympus FV1000). Cells were visualized with
differential interference contrast. For each experiment, a random field of
view was imaged for a total of 10 min (200 frames) and the area of NETs
(mm2) was quantified per field of view over 10 min with Volocity 5 software
(Improvision). Data are expressed as total area (mm2) covered by NETs per
field of view over 10 min of imaging (area under the curve of area versus
time plot).
Statistical Analysis
All data are presented asmean values ± SEM. A student’s t test (for parametric
data) or Mann-Whittney U test (for nonparametric data) was used to determine
the significance between population means when two groups were compared.
When more than two groups were compared, a one-way analysis of variance
with post-hoc Bonferroni test (for parametric data) or a Kruskal-Wallis with
post-hoc Dunn’s test (for nonparametric data) was used for multiple com-
parisons. Statistical significance was set at p < 0.05.
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